Levels of PS1 complexes are increased in CSF samples from autopsy-confirmed Alzheimer’s disease (AD) cases and were found to be more stable than complexes in CSF from control subjects. This evidence concerns the gene PSEN1 and early-onset autosomal dominant Alzheimer disease.